MNI BRIEF: Panetta Says ECB On Course For Inflation Target

MNI BRIEF: China Yuan Supported By Exports, Short Swing Sees

MNI BRIEF: RRR Trim A Better Option Than Rate Cut Now: BOC

MNI China Daily Summary: Wednesday, June 26

MNI DATA TABLE: MNI China Interbank Liquidity Index (Jun) - 1

MNI CHINA LIQUIDITY INDEX: CONDITIONS TIGHTEN IN JUNE

US EIA: CRUDE OIL STOCKS EX SPR +3.59M TO 460.7M JUN 21 WK

MNI: US MAY NEW HOME SALES -11.3% TO 0.619M SAAR

EZ/UK Bond Supply Calendar: 5/10-year BTPs / CCTeu Due Thursday​

RPT-MNI: Canada Sticks To Fiscal Anchors, Spends Chunk Of Windfall

MNI BRIEF: Poilievre Calls QE 'Scam' And Would Limit BOC Remit

© 1982-2024 MNI. All rights reserved.
Terms | Privacy
Log Out
Free Trial

Markets Remain Concerned Over Vaccine Efficacy Against New Strains (1/2)

GLOBAL

There has been much concern among markets over the suitability of the tried-and-tested vaccine candidates from Pfizer, Moderna, AstraZeneca against new mutations of COVID-19, particularly the new super strains appearing in the UK and South Africa.

Both Pfizer/BioNTech and Moderna have announced they're testing their candidates against the UK strain and both companies have made positive comments:

  • Moderna: says expects immunity from its vaccine to protect against variants and is performing more tests in the coming weeks.
  • Pfizer/BioNTech: Pfizer is 'generating' data on how well blood samples from immunized candidates reacts against the new UK strain. BioNTech CEO is 'confident' their vaccine works, but further studies are needed to make sure.
MNI London Bureau | +44 203-865-3809 | edward.hardy@marketnews.com
EM BulletHomepagemarkets-real-timeFixed Income BulletsBulletMarketsEmerging Market NewsForeign Exchange Bullets

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.